Skip to main navigation
Icosavax, Inc.
  • About
    • Overview
    • Executive team
    • Board of directors
    • Scientific advisory board & key advisors
    • Contact
  • VLP Technology
    • Overview
    • Publications
  • Pipeline
    • Overview
    • IVX-A12 (RSV/hMPV)
    • COVID-19
    • Flu
  • Investors & News
    • Overview
    • News & events
    • Stock information
    • Financials
    • Governance
    • IR resources
  • Careers
    • Overview
    • Benefits
    • Open positions
    • Diversity & inclusion

Financials

  • SEC Filings
  • Quarterly Results

Financials

Quarterly results

Show all

2022

Q3

  • Icosavax Reports Third Quarter Financial Results and Provides Corporate Update

Q2

  • Icosavax Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Q1

  • Icosavax Reports First Quarter 2022 Financial Results and Provides Corporate Update

2021

Q4

  • Icosavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
  • Form 10-K

Q3

  • Icosavax Reports Third Quarter 2021 Financial Results and Provides Corporate Update
  • Form 10-Q

Q2

  • Icosavax Reports Second Quarter 2021 Financial Results and Provides Corporate Update
  • Form 10-Q
Print
RSS feed
Contact  IR
Investor Email Alerts
Icosavax, Inc.
Contact

Icosavax, Inc.
1930 Boren Ave, Suite 1000
Seattle, WA 98101

ir@icosavax.com
  • Privacy policy
  • Terms of Use
Twitter Facebook LinkedIn
©2023 Icosavax, Inc. All Rights Reserved.